Total Synthesis of Callyaerin A

  • ChemPubSoc Europe Logo
  • Author: Angewandte Chemie International Edition
  • Published Date: 10 March 2018
  • Source / Publisher: Angewandte Chemie International Edition/Wiley-VCH
  • Copyright: Wiley-VCH Verlag GmbH & Co. KGaA
thumbnail image: Total Synthesis of Callyaerin A

Tuberculosis (TB), a highly contagious and airborne disease caused by Mycobacterium tuberculosis, is a leading cause of mortality worldwide. Callyaerin A is a cyclic peptide derived from the Indonesian marine sponge Callyspongia aerizusa. It features a rare (Z)-2,3-diaminoacrylamide (DAA) moiety and is a potent inhibitor of M. tuberculosis with no cytotoxicity observed in human cells.


Margaret A. Brimble, University of Auckland, New Zealand, and colleagues have successfully executed the first synthesis of callyaerin A. The solid phase synthesis of the linear precursor to callyaerin A uses an Fmoc-protected formylglycine-diethylacetal as a masked form of formylglycine (FMoc = fluorenylmethyloxycarbonyl). An intramolecular cyclization between the formylglycine and the N-terminal amine of the linear peptide precursor was used to construct the rare DAA bridge.


Variable-temperature NMR studies of both callyaerin A and its all-amide analogue demonstrated the high conformational rigidity imposed by the DAA moiety on the cyclic peptide structure. The all-amide analogue was inactive against TB. This highlights the important role that the rare DAA moiety plays for bioactivity. Thus, the DAA group has potential as a peptide conformation constraining agent.


 

Article Views: 1402

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

Bookmark and Share

If you would like to reuse any content, in print or online, from ChemistryViews.org, please contact us first for permission. more


CONNECT:

ChemistryViews.org on Facebook

ChemistryViews.org on Twitter ChemistryViews.org on YouTube ChemistryViews.org on LinkedIn Sign up for our free newsletter


A product of ChemPubSoc Europe (16 European Chemical Societies)and Wiley-VCH